2000-01-27 · Notice · 00-1872
Determination of Regulatory Review Period for Purposes of Patent Extension; GlucaGen®
Glucagon
Open attributed record →Federal Register publication year
2000 FDA Federal Register peptide records
1 documents attributed to FDA and HHS and published in 2000, connected only through exact reviewed peptide-name matches.